BioSpace News Archive

ITUS today announced that it has entered into a CRADA with Moffitt Cancer Center, to advance toward human clinical testing, a CAR-T technology aimed initially at Ovarian Cancer, and eventually additional solid tumors.

CanniMed and Newstrike will host a conference call and a webcast accompanied by slides to discuss the recently announced transaction on Monday, November 20, 2017 at 10:00 AM EST.

TTI-2341 had potent activity against a broad range of EGFR variants, including disease-relevant mutants T790M and C797S.

The updated FluoroFinder tool, available at NovusBio.com via the Flow Cytometry Panel Builder tool, has better performance and offers new features including Spectra Viewer and Spillover Popups.

“With 1,000 Hybrid ORs installed worldwide, we have more experience in designing and implementing these spaces than any other company,” said Chris Odom, President of Surgical Workflows, Getinge USA.

The app update includes support for DarioHealth’s new Lightning compatible device for iPhone 7 and iPhone 8 which was recently awarded the CE Mark.

Daiichi Sankyo today announced the first patient has been enrolled in DESTINY-Gastric01, a pivotal phase II study in Japan and South Korea evaluating the safety and efficacy of DS-8201, an investigational HER2-targeting ADC, in patients with HER2-positive advanced gastric or gastroesophageal junction adenocarcinoma resistant or refractory to trastuzumab.

The collaborative study was led by Theodore Jardetzky, PhD, Professor of Structural Biology at Stanford University and involved researchers at Stanford University and Northwestern University.

As stated in the 10-Q, Jaguar registered net income and comprehensive income of approximately $4.75 million in third quarter of 2017.

This year’s CPhI awards attracted more than 200 entries in 19 categories. MJR PharmJet brought forward the MicroJet Reactor Technology for the continuous synthesis of nanoparticles under GMP conditions winning the first prize in the ‘Manufacturing Technology and Equipment’ category.